Evaluation of surgeon-performed ultrasound usage amongst Australian and New Zealand Endocrine Surgeons

Jessica Wong, J. A. Miller, Ian Bennett
{"title":"Evaluation of surgeon-performed ultrasound usage amongst Australian and New Zealand Endocrine Surgeons","authors":"Jessica Wong, J. A. Miller, Ian Bennett","doi":"10.21037/aot-22-8","DOIUrl":null,"url":null,"abstract":"Background: Surgeon-performed ultrasound (US) is increasingly embraced by surgeons worldwide as an integral part of patient assessment. Its usage within Australian and New Zealand Endocrine Surgeons (ANZES) is not well documented. This study aims to evaluate current usage patterns and to determine suitable future training models. Methods: An online survey was sent to members of ANZES between August and September 2021, with emphasis on practice demographics, access and usage of US, US training and accreditation. Results: Of 125 surveys sent, 52 were returned (42%). Most respondents were metropolitan based (90%), worked in both public and private sectors (81%) and practiced both breast and endocrine surgery, with some general surgery (38%). A preponderance of surgeons had access to US equipment (73%) and 42% believed US is essential for best practice in endocrine surgery. Thirty-seven percent of surgeons performed more than 20 US per month, and 40% of respondents perform US guided fine needle aspiration biopsy (FNAB). Ultrasounds were also used in theatre as an adjunct for parathyroid (73%), thyroid (38%) and cervical lymph node surgery (44%). Most surgeons underwent formal training post Fellowship (81%) and 38% have Australasian Society for Ultrasound in Medicine Certificate in Clinician Performed Ultrasound (ASUM CCPU) accreditation. Surgeons strongly favoured post fellowship US training for future endocrine surgical trainees (88%). Conclusions: The survey demonstrates that surgeon-performed US is significantly embraced by endocrine surgeons, with 80% of respondents overall and 92.9% of those with access to US, indicating that surgeon-performed US is essential or at least very important for best practice. US is used frequently in the office and theatre settings. There is an important need for the development and formalization of endocrine US training courses from the SET/Registrar level through to the post-Fellowship environment.","PeriodicalId":92168,"journal":{"name":"Annals of thyroid","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of thyroid","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/aot-22-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Surgeon-performed ultrasound (US) is increasingly embraced by surgeons worldwide as an integral part of patient assessment. Its usage within Australian and New Zealand Endocrine Surgeons (ANZES) is not well documented. This study aims to evaluate current usage patterns and to determine suitable future training models. Methods: An online survey was sent to members of ANZES between August and September 2021, with emphasis on practice demographics, access and usage of US, US training and accreditation. Results: Of 125 surveys sent, 52 were returned (42%). Most respondents were metropolitan based (90%), worked in both public and private sectors (81%) and practiced both breast and endocrine surgery, with some general surgery (38%). A preponderance of surgeons had access to US equipment (73%) and 42% believed US is essential for best practice in endocrine surgery. Thirty-seven percent of surgeons performed more than 20 US per month, and 40% of respondents perform US guided fine needle aspiration biopsy (FNAB). Ultrasounds were also used in theatre as an adjunct for parathyroid (73%), thyroid (38%) and cervical lymph node surgery (44%). Most surgeons underwent formal training post Fellowship (81%) and 38% have Australasian Society for Ultrasound in Medicine Certificate in Clinician Performed Ultrasound (ASUM CCPU) accreditation. Surgeons strongly favoured post fellowship US training for future endocrine surgical trainees (88%). Conclusions: The survey demonstrates that surgeon-performed US is significantly embraced by endocrine surgeons, with 80% of respondents overall and 92.9% of those with access to US, indicating that surgeon-performed US is essential or at least very important for best practice. US is used frequently in the office and theatre settings. There is an important need for the development and formalization of endocrine US training courses from the SET/Registrar level through to the post-Fellowship environment.
评估外科超声在澳大利亚和新西兰内分泌外科医生中的应用
背景:外科超声(US)越来越多地被世界各地的外科医生所接受,作为患者评估的一个组成部分。它的使用在澳大利亚和新西兰内分泌外科医生(ANZES)没有很好的记录。本研究旨在评估当前的使用模式,并确定合适的未来培训模式。方法:在2021年8月至9月期间向ANZES成员发送在线调查,重点是实践人口统计,美国,美国培训和认证的获取和使用。结果:共发送125份问卷,回收52份(42%)。大多数答复者来自大都市(90%),在公共和私营部门工作(81%),从事乳房和内分泌外科手术,以及一些普通外科手术(38%)。有优势的外科医生使用美国设备(73%),42%的人认为美国是内分泌外科最佳实践的必要条件。37%的外科医生每月手术超过20次,40%的受访者进行了美国引导的细针穿刺活检(FNAB)。超声在手术室也被用作甲状旁腺(73%)、甲状腺(38%)和颈部淋巴结手术(44%)的辅助检查。大多数外科医生在实习后接受了正式的培训(81%),38%的外科医生获得了澳大利亚超声学会临床医师超声医学证书(ASUM CCPU)认证。外科医生强烈支持对未来内分泌外科培训生进行博士后美国培训(88%)。结论:调查显示,外科医生进行的超声检查被内分泌外科医生明显接受,总体上有80%的受访者和92.9%的受访者可以进行超声检查,这表明外科医生进行的超声检查对于最佳实践是必不可少的,或者至少是非常重要的。US经常用于办公室和剧院。从SET/注册员级别到研究金后环境,非常需要发展和正式确定美国内分泌培训课程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.90
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信